DesignMedix: Overcoming Drug Resistance
DesignMedix places great emphasis on tackling problems of drug resistant diseases, such as malaria, bacteria, and cancer.
DesignMedix places great emphasis on tackling problems of drug resistant diseases, such as malaria, bacteria, and cancer.
An estimated 2.85 billion people worldwide were at risk of contracting malaria in 2009, according to a new report published Tuesday in the journal PLos Neglected Tropical Diseases.
Poor regulations and substandard use could be to blame for growing resistance to a leading anti-malaria drug, researchers say.
Bioject Medical Technologies, a developer of needle-free injection systems, has signed a cooperative R&D agreement with the U.S. Navy to use Bioject’s technology in a malaria vaccine the Navy is developing.
Copyright © 2024 | WordPress Theme by MH Themes